Duchenne News Tags: Avidity Biosciences

April 24, 2023
Avidity announces Fast Track designation to AOC 1044 for the treatment of Duchenne
March 20, 2023
Avidity Biosciences provides an update on the Phase 1/2 MARINA™ trial of AOC 1001 in adults with myotonic dystrophy type 1.
December 14, 2022
Avidity announces positive AOC 1001 date from preliminary MARINA study assessment

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open